sarcoma

systematic review meta-analysis network meta-analysis

Select Miscellaneous All type of patient       whole population pazopanib      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result
Miscellaneous
not classified
Eribulin phase 3 (Schöffski ), 2016	eribulin	dacarbazine				-
Spanish Group for Research on Sarcomas , 2011	gemcitabine plus dacarbazine	dacarbazine				-
Demetri, 2016      NCT	trabectedin	dacarbazine				-
TSAR    NCT	trabectedin	SOC				-
phase 2 ET743-STS-201    NCT	trabectedin	trabectedin				-
pazopanib
PALETTE (van der Graaf), 2012      NCT	pazopanib	placebo				suggesting